Hexamethylene bisacetamide

CAS No. 3073-59-4

Hexamethylene bisacetamide( HMBA | NSC 95580 )

Catalog No. M13980 CAS No. 3073-59-4

A cell differentiation inducer that inhibits activation of NF-κB function, Akt and ERK/MAPK cascade.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 38 Get Quote
50MG 59 Get Quote
100MG 82 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Hexamethylene bisacetamide
  • Note
    Research use only, not for human use.
  • Brief Description
    A cell differentiation inducer that inhibits activation of NF-κB function, Akt and ERK/MAPK cascade.
  • Description
    A cell differentiation inducer that inhibits activation of NF-κB function, Akt and ERK/MAPK cascade; causes MEL cell differentiation by acting as a selective BD2 (bromodomain 2) inhibitor, kills Myc-induced lymphoma cells in vitro and in vivo; also is a small molecule inducer of HEXIM1 expression, inhibits the metastasis of breast cancer to lung in PyMT mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    HMBA | NSC 95580
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3073-59-4
  • Formula Weight
    200.28
  • Molecular Formula
    C10H20N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (124.83 mM)
  • SMILES
    CC(NCCCCCCNC(C)=O)=O
  • Chemical Name
    1,6-Hexanebisacetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ketchart W, et al. Oncogene. 2013 Aug 15;32(33):3829-39. 2. Nilsson LM, et al. Cancer Res. 2016 Apr 15;76(8):2376-83. 3. Dey A, et al. Cell Cycle. 2008 Dec;7(23):3759-67.
molnova catalog
related products
  • CD 161

    A potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively.

  • SJ830599

    SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1.

  • MS-417

    MS-417 (GTPL-7512) is a highly specific BET bromodomain inhibitor that binds to BRD4-BD1 and BRD4 BD2 with Kd of 36.1 uM and 25.4 uM respectively.